4.7 Review

Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations

Robert R. Edwards et al.

Summary: There is a large variability in individual response to pain treatments, even those that are highly effective, which has led to calls for personalized approaches to treating patients with pain. Precision pain medicine aims to determine the optimal treatments for specific patients by using empirically based algorithms. This review surveys the current state of precision pain medicine and presents evidence-based recommendations for its application in chronic pain research.

JOURNAL OF PAIN (2023)

Article Multidisciplinary Sciences

Gut enterochromaffin cells drive visceral pain and anxiety

James R. R. Bayrer et al.

Summary: Gastrointestinal discomfort is a common symptom of gut disorders and chronic visceral pain, especially in patients with irritable bowel syndrome. Enterochromaffin (EC) cells, which are rare serotonergic neuroendocrine cells in the gut epithelium, play a crucial role in detecting and transmitting noxious stimuli to nerve endings. The activation and dysfunction of EC cells are associated with hypersensitivity to gut distension and the inflammatory effects of certain fatty acids. Additionally, prolonged EC cell activation leads to persistent visceral hypersensitivity and anxiety-like behaviors. Furthermore, there are notable sex differences in the involvement of the EC cell-mucosal afferent circuit.

NATURE (2023)

Review Biochemistry & Molecular Biology

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

Chen Zhang et al.

Summary: Ferroptosis, an iron-dependent form of cell death, plays a crucial role in tumor suppression and has the potential to reverse cancer therapy resistance.

MOLECULAR CANCER (2022)

Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

Review Neurosciences

Innovations and advances in modelling and measuring pain in animals

Katelyn E. Sadler et al.

Summary: This review discusses recent trends in preclinical pain modelling and provides recommendations for experimental designs that may increase translational success. Best practices in pain behaviour testing have shifted over the past decade due to technological advancements and the emphasis on rigor and reproducibility. The discussion focuses on four fundamental decisions in pain behavior experiments: choice of subject, choice of assay, laboratory environment, and choice of outcome measures.

NATURE REVIEWS NEUROSCIENCE (2022)

Article Cell Biology

Blockade of GCH1/BH4 Axis Activates Ferritinophagy to Mitigate the Resistance of Colorectal Cancer to Erastin-Induced Ferroptosis

Qian Hu et al.

Summary: This study reveals that GCH1/BH4 metabolism is a major factor contributing to the resistance of colorectal cancer cells to erastin-induced ferroptosis. Inhibiting GCH1/BH4 metabolism promotes ferroptosis by activating ferritinophagy, suggesting a novel therapeutic strategy for colorectal cancer.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Oncology

Ferroptosis in cancer and cancer immunotherapy

Lei Zhao et al.

Summary: Ferroptosis, a newly identified type of cell death dependent on lipid peroxidation, plays a vital role in cancer treatment as a potential strategy to overcome drug resistance in traditional therapies.

CANCER COMMUNICATIONS (2022)

Article Cell Biology

Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer

Shane J. F. Cronin et al.

Summary: This study revealed that EGFR/KRAS signaling triggers increased expression of Gch1, contributing to pain perception. Inhibiting EGFR reduces GCH1 and BH4 expression and exerts analgesic effects. Additionally, GCH1/BH4 acts downstream of KRAS to drive lung cancer. These findings suggest that pharmacological modulation of GCH1 and BH4 expression could be a potential therapeutic strategy for pain management.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Review Nutrition & Dietetics

Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders

Tarkan Karakan et al.

Summary: The composition and function of gut microbiota play a crucial role in functional gastrointestinal disorders, with a bidirectional communication between the gut and the central nervous system. Antibiotic-induced dysbiosis is identified as a significant factor for the occurrence of these disorders, affecting the gut-brain axis and potentially leading to cognitive and mood disorders. Both animal and human trials provide strong evidence for the causal relationship between gut microbiota and brain functions, highlighting new therapeutic implications for pathogenic pathways.

NUTRIENTS (2021)

Article Pharmacology & Pharmacy

Sulfasalazine alleviates neuropathic pain hypersensitivity in mice through inhibition of SGK-1 in the spinal cord

Sai Yasukochi et al.

Summary: Diurnal variations in pain hypersensitivity are common in chronic pain disorders, with exacerbation of neuropathic pain hypersensitivity depending on glucocorticoid secretion. The study found that the drug SSZ has inhibitory effects on SGK-1 in the spinal cord, and concomitant administration with FBX can enhance its anti-neuropathic pain effects.

BIOCHEMICAL PHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Is hyaluronic acid the perfect excipient for the pharmaceutical need?

Daniela Harrer et al.

Summary: Hyaluronic acid, as an important excipient for pharmaceutical products, has beneficial properties such as solubility, biocompatibility, and biodegradation. Chemical modifications can improve its properties and offer opportunities for novel drug delivery systems. It is widely researched for various administrations in fields like rheumatology, ophthalmology, and cancer treatment, showing promising prospects for future pharmaceutical administration.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Cell Biology

Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use

Jinfu Zhuang et al.

Summary: The study revealed that xCT is up-regulated in gastric cancer and is associated with tumor stage and patient prognosis. Sulfasalazine can attenuate the proliferation, colony formation, migration, and invasion of gastric cancer cells.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Endocrinology & Metabolism

Molecular and metabolic bases of tetrahydrobiopterin (BH4) deficiencies

Nastassja Himmelreich et al.

Summary: Tetrahydrobiopterin (BH4) deficiency, caused by genetic variants in genes involved in cofactor biosynthesis and recycling, leads to reduced cofactor levels and potential systemic hyperphenylalaninemia and neurological sequelae. The clinical impact of these genetic variants vary and are crucial for genetic counseling and precision medicine development.

MOLECULAR GENETICS AND METABOLISM (2021)

Article Clinical Neurology

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice

Katja Schmitz et al.

Summary: Depletion of enzyme cofactor BH4 in T-cells prevents proliferation and may drive autoimmunity. Low BH4 levels in MS patients with high disability scores, along with increased neopterin levels, suggest a role for BH4 replenishment in modulating immune response. Treating EAE mice with sapropterin results in exacerbated disease scores and lipid deregulations associated with blood-brain barrier disruptions, supporting the idea that BH4 strengthens autoimmune CNS diseases through lipid imbalances.

NEUROTHERAPEUTICS (2021)

Article Rheumatology

Efficacy and Safety of Diclofenac-Hyaluronate Conjugate (Diclofenac Etalhyaluronate) for Knee Osteoarthritis: A Randomized Phase III Trial in Japan

Yoshihiro Nishida et al.

Summary: Intraarticular injection of diclofenac covalently linked to hyaluronic acid (DF-HA) showed significant improvement in pain subscale scores compared to placebo over 12 weeks in patients with knee osteoarthritis, although anaphylactic reactions were observed, requiring further safety evaluation.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Chemistry, Medicinal

Virtual screening to identify potent sepiapterin reductase inhibitors

Hua Gao et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Pharmacology & Pharmacy

Aspirin and its pleiotropic application

Jolanta Hybiak et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Article Chemistry, Multidisciplinary

GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling

Vanessa A. N. Kraft et al.

ACS CENTRAL SCIENCE (2020)

Review Genetics & Heredity

Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies

Thomas Opladen et al.

ORPHANET JOURNAL OF RARE DISEASES (2020)

Review Biochemistry & Molecular Biology

Targeted protein degradation: current and future challenges

Alexander Hanzl et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2020)

Review Neurosciences

Kynurenine and Tetrahydrobiopterin Pathways Crosstalk in Pain Hypersensitivity

Ananda Staats Pires et al.

FRONTIERS IN NEUROSCIENCE (2020)

Article Neurosciences

Mechanisms Mediating High-Molecular-Weight Hyaluronan-Induced Antihyperalgesia

Ivan J. M. Bonet et al.

JOURNAL OF NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers

Mariluz Soula et al.

NATURE CHEMICAL BIOLOGY (2020)

Article Chemistry, Medicinal

Systematic Investigation of the Permeability of Androgen Receptor PROTACs

Duncan E. Scott et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Multidisciplinary Sciences

Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis

Nandini Verma et al.

SCIENCE ADVANCES (2020)

Article Pharmacology & Pharmacy

Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat

James T. Meyer et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Article Multidisciplinary Sciences

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Weimin Wang et al.

NATURE (2019)

Article Chemistry, Medicinal

Fragment-Based Discovery of Novel Potent Sepiapterin Reductase Inhibitors

Jo Alen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Neurosciences

T Cells as an Emerging Target for Chronic Pain Therapy

Geoffroy Laumet et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Neurosciences

Combining Human and Rodent Genetics to Identify New Analgesics

Alban Latremoliere et al.

NEUROSCIENCE BULLETIN (2018)

Review Polymer Science

Hyaluronic Acid in the Third Millennium

Arianna Fallacara et al.

POLYMERS (2018)

Review Chemistry, Medicinal

Current Screening Methodologies in Drug Discovery for Selected Human Diseases

Olga Maria Lage et al.

MARINE DRUGS (2018)

Article Multidisciplinary Sciences

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

Shane J. F. Cronin et al.

NATURE (2018)

Article Clinical Neurology

Sepiapterin reductase deficiency: Report of 5 new cases

Sarah AlSubhi et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2017)

Review Biochemistry & Molecular Biology

The role of carbonyl reductase 1 in drug discovery and development

Sophia M. Shi et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)

Article Biochemistry & Molecular Biology

Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways

Nicholas W. Bellono et al.

Article Biochemistry & Molecular Biology

Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid

Hirohito Haruki et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Immunology

Endogenous analgesia mediated by CD4+ T lymphocytes is dependent on enkephalins in mice

Lilian Basso et al.

JOURNAL OF NEUROINFLAMMATION (2016)

Article Endocrinology & Metabolism

Urine sepiapterin excretion as a new diagnostic marker for sepiapterin reductase deficiency

Claudia Carducci et al.

MOLECULAR GENETICS AND METABOLISM (2015)

Article Multidisciplinary Sciences

CD11b+Ly6G- myeloid cells mediate mechanical inflammatory pain hypersensitivity

Nader Ghasemlou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Pharmacology & Pharmacy

Sulfa Drugs Inhibit Sepiapterin Reduction and Chemical Redox Cycling by Sepiapterin Reductase

Shaojun Yang et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)

Article Clinical Neurology

Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene

J. Koht et al.

ACTA NEUROLOGICA SCANDINAVICA (2014)

Review Biochemistry & Molecular Biology

Tetrahydrobiopterin in Cardiovascular Health and Disease

Jennifer K. Bendall et al.

ANTIOXIDANTS & REDOX SIGNALING (2014)

Article Gastroenterology & Hepatology

Endogenous Regulation of Visceral Pain via Production of Opioids by Colitogenic CD4+ T Cells in Mice

Jerome Boue et al.

GASTROENTEROLOGY (2014)

Article Biochemistry & Molecular Biology

Novel Interaction of Ornithine Decarboxylase with Sepiapterin Reductase Regulates Neuroblastoma Cell Proliferation

Ingo Lange et al.

JOURNAL OF MOLECULAR BIOLOGY (2014)

Review Clinical Neurology

Capsaicinoids in the treatment of neuropathic pain: a review

John F. Peppin et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2014)

Editorial Material Pharmacology & Pharmacy

Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines

D. C. Swinney

CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)

Review Gastroenterology & Hepatology

Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets

Gary M. Mawe et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)

Editorial Material Clinical Neurology

VERY EARLY PATTERN OF MOVEMENT DISORDERS IN SEPIAPTERIN REDUCTASE DEFICIENCY

Vincenzo Leuzzi et al.

NEUROLOGY (2013)

Article Multidisciplinary Sciences

Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs

Hirohito Haruki et al.

SCIENCE (2013)

Article Pharmacology & Pharmacy

Tissue Distribution, Ontogeny, and Chemical Induction of Aldo-Keto Reductases in Mice

Matthew Pratt-Hyatt et al.

DRUG METABOLISM AND DISPOSITION (2013)

Review Pharmacology & Pharmacy

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher A. Lipinski et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Article Clinical Neurology

Sepiapterin reductase deficiency: A Treatable Mimic of Cerebral Palsy

Jennifer Friedman et al.

ANNALS OF NEUROLOGY (2012)

Review Oncology

A Comprehensive Survey of Ras Mutations in Cancer

Ian A. Prior et al.

CANCER RESEARCH (2012)

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.

Article Pharmacology & Pharmacy

Analgesia by inhibiting tetrahydrobiopterin synthesis

Michael Costigan et al.

CURRENT OPINION IN PHARMACOLOGY (2012)

Review Biochemistry & Molecular Biology

Tetrahydrobiopterin: biochemistry and pathophysiology

Ernst R. Werner et al.

BIOCHEMICAL JOURNAL (2011)

Review Biochemistry & Molecular Biology

GCH1, BH4 and Pain

Alban Latremoliere et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)

Article Biochemistry & Molecular Biology

Role of Increased Guanosine Triphosphate Cyclohydrolase-1 Expression and Tetrahydrobiopterin Levels upon T Cell Activation

Wei Chen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis

Christopher Chidley et al.

NATURE CHEMICAL BIOLOGY (2011)

Article Biotechnology & Applied Microbiology

How were new medicines discovered?

David C. Swinney et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Biochemistry & Molecular Biology

Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints

Dorota F. Zielinska et al.

Letter Clinical Neurology

Sepiapterin Reductase Deficiency: Two Indian Siblings with Unusual Clinical Features

Gurusidheshwar M. Wali et al.

MOVEMENT DISORDERS (2010)

Review Anesthesiology

The necessity of animal models in pain research

Jeffrey S. Mogil et al.

Article Clinical Neurology

Sleep and Rhythm Consequences of a Genetically Induced Loss of Serotonin

Smaranda Leu-Semenescu et al.

Review Neurosciences

Animal models of pain: progress and challenges

Jeffrey S. Mogil

NATURE REVIEWS NEUROSCIENCE (2009)

Article Multidisciplinary Sciences

Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation

Alicia R. Folgueras et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

A brain-specific decrease of the tyrosine hydroxylase protein in sepiapterin reductase-null mice - as a mouse model for Parkinson's disease

Chisato Takazawa et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Biochemistry & Molecular Biology

Human carbonyl reductase 4 is a mitochondrial NADPH-dependent quinone reductase

Satoshi Endo et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Endocrinology & Metabolism

Sulfasalazine blocks the development of tactile allodynia in diabetic rats

Liliana N. Berti-Mattera et al.

DIABETES (2008)

Article Agriculture, Multidisciplinary

Absorption, Uptake and Tissue Affinity of High-Molecular-Weight Hyaluronan after Oral Administration in Rats and Dogs

Lajos Balogh et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)

Article Cell Biology

Tissue Distribution of Human AKR1C3 and Rat Homolog in the Adult Genitourinary System

Joseph Azzarello et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)

Article Endocrinology & Metabolism

Two Greek siblings with sepiapterin reductase deficiency

Marcel M. Verbeekac et al.

MOLECULAR GENETICS AND METABOLISM (2008)

Article Biochemistry & Molecular Biology

GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence

Irmgard Tegeder et al.

NATURE MEDICINE (2006)

Article Endocrinology & Metabolism

Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia

Nico G. Abeling et al.

MOLECULAR GENETICS AND METABOLISM (2006)

Article Genetics & Heredity

A murine model for human sepiapterin-reductase deficiency

S Yang et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2006)

Article Biochemical Research Methods

Synthesis and evaluation of hydrolyzable hyaluronan-tethered bupivacaine delivery systems

DA Gianolio et al.

BIOCONJUGATE CHEMISTRY (2005)

Article Gastroenterology & Hepatology

The role of mast cells in the pathogenesis of pain in chronic pancreatitis

WA Hoogerwerf et al.

BMC GASTROENTEROLOGY (2005)

Review Endocrinology & Metabolism

The metabolic and molecular bases of tetrahydroblopterin-responsive phenylalanine hydroxylase deficiency

N Blau et al.

MOLECULAR GENETICS AND METABOLISM (2004)

Article Biochemistry & Molecular Biology

Tetrahydrobiopterin is synthesized from 6-pyruvoyl-tetrahydropterin by the human aldo-keto reductase AKR1 family members

T Iino et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2003)

Article Endocrinology & Metabolism

Detection of sepiapterin in CSF of patients with sepiapterin reductase deficiency

G Zorzi et al.

MOLECULAR GENETICS AND METABOLISM (2002)

Article Biochemistry & Molecular Biology

Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency

G Zorzi et al.

JOURNAL OF NEUROCHEMISTRY (2002)

Article Multidisciplinary Sciences

Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation

KM Sakamoto et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)